[1] |
HAO Xiao, ZHAO Mei, WANG Wenjing, ZHANG Feifei, LIU Huiliang, DANG Yi, LI Shuren, QI Xiaoyong.
Application of sodium-glucose cotransporter 2 inhibitors in acute myocardial infarction
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(7): 824-831.
|
[2] |
HUANG Zhiwei, LI Yi, XU Xiaoyong, ZHANG Lei, SHEN Yifeng, LI Huafang.
Comparison of calculation results of five population pharmacokinetic analysis tools
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(5): 525-535.
|
[3] |
LUO Mingjie, LIU Runhan, ZHOU Jie, WANG Zhenlei.
Comparison of common parameter estimation methods in NONMEM 7.5.1.: A case study of ibuprofen injection in Chinese healthy adult population
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(3): 290-298.
|
[4] |
MA Guangli, ZHANG Jing.
Application of quantitative pharmacology in vaccine research and de-velopment: overview and prospect
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2023, 28(3): 315-322.
|
[5] |
YE Hongbo, SONG Yangyang, XUE Ling, RUI Jianzhong.
Meropenem population pharmacokinetic model for the Chinese elderly established by model-based META analysis
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(9): 984-990.
|
[6] |
FU Yongfang, GUO Yixun, WANG Jing, LI Wenxiong, ZHANG Yan.
Research progress on experimental pharmacology models of sarcopenia from the view of senescence
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(8): 892-898.
|
[7] |
YE Xiaodi, MIAO Yunping, CHEN Aiying, CHENG Min, TIAN Xuejun, ZHENG Gaoli .
Optimization and verification of orthotopic non-muscle invasive bladder cancer model in nude mice
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(4): 473-480.
|
[8] |
PENG Juan, LI Ranyi, FAN Linlin, LI Xiaoyu, LV Qianzhou, ZOU Yunzeng.
Progress of pharmacotherapy for myocardial hypertrophy and cardiac remodeling
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(4): 382-389.
|
[9] |
LIAN Jinfang, LIU Yiwei, LIN Cuihong, HUANG Pinfang, LIN Rongfang.
Comparison of prediction accuracy between warfarin PPK/PD model and multiple regression dose models
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(3): 267-273.
|
[10] |
ZHANG Jinhua, LIU Maobai, CAI Mingzhi, ZHENG Yingli, LAO Haiyan, XIANG Qian, DU Liping, ZHU Zhu, DONG Jing, ZUO Xiaocong, LI Xingang, SHANG Dewei, CHEN Bing, YE Yanrong, WANG Yuzhu, GAO Jianjun, ZHANG Jian, CHEN Wansheng, XIE Haitang, JIAO Zheng.
Model informed precision dosing of warfarin: China expert consensus report (2022 version)
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(11): 1201-1212.
|
[11] |
XU Liying, ZHANG Gaosong, HUANG Xiaomin, HUANG Jihan, WANG Shuhua.
Clinical efficacy and modeling evaluation of He-wei-zhi-xie capsules in treating diarrhea patients
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(1): 47-55.
|
[12] |
LIU Wei, XUE Junsheng, YU Zhiheng, WANG Ziyu, CHEN Rong, ZHOU Tianyan.
Interpretation of pharmacokinetic-based criteria for supporting alternative dosing regimens of programmed cell death receptor-1 (PD-1) or programmed cell death-ligand 1 (PD-L1) blocking antibodies for treatment of patients with cancer guidance for industry
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(1): 86-94.
|
[13] |
LIN Liangmo, FU Xiangjun, ZHONG Lili, WANG Hefang, WU Qiongshi, XIAO Jian.
Establishment of population pharmacokinetics model of vancomycin in patients with Neutropenia
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(9): 1014-1022.
|
[14] |
ZHOU Han, LIU Xiaodong.
Application of physiologically based pharmacokinetic model in drug development and several questions being thought
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(8): 889-913.
|
[15] |
LIU Wenjing, WU Zhitao, PAN Guoyu.
Early dectection and prediction hepatotoxic risk in vitro
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(8): 923-930.
|